Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,840
Total Claims
$656K
Drug Cost
267
Beneficiaries
$2,459
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-65%
Opioid rate vs peers
0.9% vs 2.6% avg
+130%
Cost per patient vs peers
$2,459 vs $1,068 avg
+43%
Brand preference vs peers
12.9% vs 9.0% avg
Opioid Prescribing
0.9%
Opioid Rate
80
Opioid Claims
$356
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,130 claims · $419K
Generic: 7,658 claims · $233K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tetrabenazine | 15 | $60K |
| Apixaban | 181 | $45K |
| Risperidone Microspheres | 37 | $41K |
| Linagliptin | 90 | $20K |
| Insulin Detemir | 68 | $18K |
| Insulin Aspart | 85 | $17K |
| Linaclotide | 25 | $14K |
| Vibegron | 43 | $11K |
| Empagliflozin | 33 | $11K |
| Aripiprazole | 35 | $11K |
| Eslicarbazepine Acetate | 15 | $10K |
| Memantine Hcl | 169 | $10K |
| Umeclidinium Bromide | 30 | $9,612 |
| Insulin Glargine,hum.Rec.Anlog | 35 | $8,764 |
| Insulin Lispro | 26 | $7,896 |
Prescribing Profile
Patient Profile
71
Avg Age
60%
Female
2.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About